These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16873997)

  • 21. Usefulness of brachial-ankle pulse wave velocity as a predictive marker of multiple coronary artery occlusive disease in Korean type 2 diabetes patients.
    Kim HJ; Nam JS; Park JS; Cho M; Kim CS; Ahn CW; Kwon HM; Hong BK; Yoon YW; Cha BS; Kim KR; Lee HC
    Diabetes Res Clin Pract; 2009 Jul; 85(1):30-4. PubMed ID: 19398141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between brain natriuretic peptide and coronary stenosis: influence of aging].
    Suzuki N; Mori H; Hazama M; Takahashi K; Moriya M; Yano K
    J Cardiol; 2004 Mar; 43(3):117-22. PubMed ID: 15067799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased brachial-ankle pulse wave velocity is associated with impaired endothelial function in patients with coronary artery disease.
    Liu DH; Wang Y; Liao XX; Xu MG; Wang JM; Yang Z; Chen L; Lü MD; Lu K; Tao J
    Chin Med J (Engl); 2006 Nov; 119(22):1866-70. PubMed ID: 17134584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between plasma brain natriuretic peptide level and left ventricular systolic function in coronary artery disease].
    Celiński R; Grzywa-Celińska A; Cholewiński W; Stefaniak B; Tarkowska A
    Pol Merkur Lekarski; 2005 Mar; 18(105):291-4. PubMed ID: 15997635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease.
    Wolber T; Maeder M; Weilenmann D; Duru F; Bluzaite I; Riesen W; Rickli H; Ammann P
    Am J Cardiol; 2006 Sep; 98(6):764-7. PubMed ID: 16950181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.
    Taylor JA; Christenson RH; Rao K; Jorge M; Gottlieb SS
    Am Heart J; 2006 Dec; 152(6):1071-6. PubMed ID: 17161055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma B-type natriuretic peptide levels reflect the presence and severity of stable coronary artery disease in chronic haemodialysis patients.
    Niizuma S; Iwanaga Y; Yahata T; Goto Y; Kita T; Miyazaki S; Nakahama H
    Nephrol Dial Transplant; 2009 Feb; 24(2):597-603. PubMed ID: 18762474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease.
    Nakamura M; Yamashita T; Yajima J; Oikawa Y; Sagara K; Koike A; Kirigaya H; Nagashima K; Sawada H; Aizawa T;
    Hypertens Res; 2010 Oct; 33(10):1018-24. PubMed ID: 20703233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function.
    Choi EY; Ha JW; Joung B; Ko YG; Choi D; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Am J Cardiol; 2008 Feb; 101(3):364-9. PubMed ID: 18237601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortic pulse pressure and aortic pulsatility are associated with angiographic coronary artery disease in women.
    Guray Y; Guray U; Altay H; Cay S; Yilmaz MB; Kisacik HL; Korkmaz S
    Blood Press; 2005; 14(5):293-7. PubMed ID: 16257875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes.
    Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T
    Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
    Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
    Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
    Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
    Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
    Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y; Shimada T; Inoue S; Shimizu H; Ohta Y; Katoh H; Nakamura K; Ishibashi Y
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.